Jacana, a leader in the outdoor cultivation and distribution of medical cannabis, has completed the first-ever international export of Jamaican medical cannabis flower, securing multiple international licenses and permits to date. The deal also saw Jacana play a central role in shaping the international regulatory process.

The historic export is linked to the company raising an initial $20 million to cultivate, develop and distribute certified medical cannabis solutions that provide natural alternatives to the artificially manufactured products in the market.

Jacana also announced the launch of a new kind of medical company that harnesses the power of nature to produce certified medical cannabis, providing natural relief for chronic pain and suffering.

Chronic pain affects 1.5 billion people worldwide, with more than 100 million people suffering in the US alone.

The investment will fuel international expansion and build on Jacana’s existing presence in Europe, North America and the Caribbean.

Advertisement

LEAVE A REPLY

Please enter your comment!
Please enter your name here